Best Practices for Helicobacter pylori Management.

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Antimicrobial therapy for Helicobacter pylori infection has historically been empirical, leading to low cure rates.
• Increasing antibiotic resistance in H. pylori strains is a significant global health concern.
• Lack of treatment outcome confirmation and modification of prescribing behavior contribute to therapeutic failure.

Purpose of the Study:

• To describe current best practices for integrating susceptibility testing into H. pylori therapy.
• To promote antimicrobial stewardship principles for H. pylori infections.
• To guide the selection of effective antimicrobial regimens based on resistance patterns.

Main Methods:

• Review of current literature and clinical guidelines on H. pylori treatment.
• Discussion of culture-based and molecular-based susceptibility testing methods.
• Classification of antimicrobial regimens based on efficacy and susceptibility data.

Main Results:

• Susceptibility testing for H. pylori is increasingly available, particularly in the United States.
• Availability of susceptibility data facilitates adoption of antimicrobial stewardship.
• Antimicrobial regimens can be categorized into empiric, susceptibility-based, and suboptimal therapies.

Conclusions:

• Integrating susceptibility testing into H. pylori therapy is crucial for improving cure rates.
• Antimicrobial stewardship, guided by susceptibility testing, optimizes treatment selection.
• Personalized H. pylori treatment based on resistance profiles enhances therapeutic success.